Macleods Recalls 3,744 Bottles of Blood Pressure Combination Pills

Macleods Pharma USA has voluntarily recalled 3,744 bottles of a three-drug blood pressure medication combining olmesartan medoxomil, amlodipine and hydrochlorothiazide after the tablets failed dissolution testing. The recall covers two lots of 40mg/10mg/12.5mg tablets, both expiring May 31, 2027, and affects pharmacies and patients nationwide who received the product. The company notified consignees by letter and began the recall October 7; the FDA classified it Class II on October 26, meaning exposure could cause temporary or reversible health effects. The recall is ongoing and follows a similar September recall of chlorthalidone tablets by Inventia Healthcare for the same dissolution failure.

Pharmacy